Bolt Biotherapeutics, Inc.

NasdaqGS:BOLT 주식 보고서

시가총액: US$28.0m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Bolt Biotherapeutics 관리

관리 기준 확인 1/4

Bolt Biotherapeutics' CEO는 Willie Quinn, May2020 에 임명되었습니다 의 임기는 4.08 년입니다. 총 연간 보상은 $ 912.18K, 48.4% 로 구성됩니다. 48.4% 급여 및 51.6% 보너스(회사 주식 및 옵션 포함). 는 $ 26.66K 가치에 해당하는 회사 주식의 0.095% 직접 소유합니다. 26.66K. 경영진과 이사회의 평균 재임 기간은 각각 0.1 년과 2.6 년입니다.

주요 정보

Willie Quinn

최고 경영자

US$912.2k

총 보상

CEO 급여 비율48.4%
CEO 임기4.1yrs
CEO 소유권0.1%
경영진 평균 재임 기간less than a year
이사회 평균 재임 기간2.6yrs

최근 관리 업데이트

Recent updates

Little Excitement Around Bolt Biotherapeutics, Inc.'s (NASDAQ:BOLT) Revenues As Shares Take 29% Pounding

May 21
Little Excitement Around Bolt Biotherapeutics, Inc.'s (NASDAQ:BOLT) Revenues As Shares Take 29% Pounding

We Think Bolt Biotherapeutics (NASDAQ:BOLT) Needs To Drive Business Growth Carefully

Mar 15
We Think Bolt Biotherapeutics (NASDAQ:BOLT) Needs To Drive Business Growth Carefully

Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?

May 13
Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?

Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?

Dec 01
Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?

Bolt Biotherapeutics: A Promised Follow Up

Aug 26

Bolt Biotherapeutics GAAP EPS of -$0.61 beats by $0.08, revenue of $1.39M beats by $0.89M

Aug 10

We're Keeping An Eye On Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Rate

Jul 27
We're Keeping An Eye On Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Rate

We're Not Very Worried About Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Rate

Apr 12
We're Not Very Worried About Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Rate

We Think Bolt Biotherapeutics (NASDAQ:BOLT) Can Afford To Drive Business Growth

Dec 03
We Think Bolt Biotherapeutics (NASDAQ:BOLT) Can Afford To Drive Business Growth

Bolt Biotherapeutics: Pioneering A New Class Of Immunotherapies

Aug 18

We're Hopeful That Bolt Biotherapeutics (NASDAQ:BOLT) Will Use Its Cash Wisely

Aug 18
We're Hopeful That Bolt Biotherapeutics (NASDAQ:BOLT) Will Use Its Cash Wisely

CEO 보상 분석

Willie Quinn 의 보수는 Bolt Biotherapeutics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$63m

Dec 31 2023US$912kUS$442k

-US$69m

Sep 30 2023n/an/a

-US$71m

Jun 30 2023n/an/a

-US$77m

Mar 31 2023n/an/a

-US$81m

Dec 31 2022US$1mUS$423k

-US$88m

Sep 30 2022n/an/a

-US$95m

Jun 30 2022n/an/a

-US$97m

Mar 31 2022n/an/a

-US$98m

Dec 31 2021US$2mUS$395k

-US$99m

Sep 30 2021n/an/a

-US$102m

Jun 30 2021n/an/a

-US$89m

Mar 31 2021n/an/a

-US$77m

Dec 31 2020US$1mUS$239k

-US$61m

보상 대 시장: Willie 의 총 보상 ($USD 912.18K )은 US 시장( $USD 683.56K ).

보상과 수익: Willie 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

Willie Quinn (53 yo)

4.1yrs

테뉴어

US$912,175

보상

Mr. William P. Quinn, also known as Willie, is CEO, President & Director of Bolt Biotherapeutics, Inc. from May 15, 2024. He has been Chief Financial Officer at Bolt Biotherapeutics, Inc. since May 2020 an...


리더십 팀

이름위치테뉴어보상소유권
William Quinn
CEO, CFO4.1yrsUS$912.18k0.095%
$ 26.7k
Edgar Engleman
Founder & Member of Scientific Advisory Boardno dataUS$70.59k3.2%
$ 896.9k
Grant Yonehiro
Chief Operating Officerless than a yearUS$839.50k0.023%
$ 6.6k
Randall Schatzman
Advisorless than a yearUS$1.75m0.027%
$ 7.6k
Edith Perez
Advisor4.2yrsUS$982.72k0.12%
$ 34.3k
Sarah Nemec
VP of Finance & Principal Accounting Officerless than a year데이터 없음0.030%
$ 8.4k
Wesley Burwell
VP & Head of Human Resources3.1yrs데이터 없음데이터 없음
Nathan Ihle
Senior Vice President of Pharmaceutical Operations2yrs데이터 없음데이터 없음
Dawn Colburn
Senior Vice President of Clinical Developmentless than a year데이터 없음데이터 없음
Michael Alonso
Senior Vice President of Researchless than a year데이터 없음데이터 없음

0.08yrs

평균 재임 기간

63.5yo

평균 연령

경험이 풍부한 관리: BOLT 의 관리팀은 경험 (평균 재직 기간 0.1 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
William Quinn
CEO, CFOless than a yearUS$912.18k0.095%
$ 26.7k
Edgar Engleman
Founder & Member of Scientific Advisory Boardless than a yearUS$70.59k3.2%
$ 896.9k
Kathleen LaPorte
Independent Director3.5yrsUS$80.59k0.0032%
$ 882.8
James Healy
Lead Independent Director3.4yrsUS$78.59k0%
$ 0
Nils Lonberg
Member of Scientific Advisory Board3.3yrs데이터 없음데이터 없음
Mahendra Shah
Independent Director7.8yrsUS$77.09k0%
$ 0
Nicole Onetto
Independent Director2.5yrsUS$75.59k0%
$ 0
Brian O'Callaghan
Independent Director2.6yrsUS$83.09k0%
$ 0
Roy Steven Herbst
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Bruce Roth
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Frank Lee
Independent Director2.6yrsUS$74.59k0%
$ 0
Lawrence Fong
Member of Scientific Advisory Boardno data데이터 없음데이터 없음

2.6yrs

평균 재임 기간

61.5yo

평균 연령

경험이 풍부한 이사회: BOLT 의 이사회경험(평균 재직 기간 2.6 년)으로 간주되지 않으므로 새 이사회가 필요합니다.